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Clinical Applications of Color Doppler
Imaging in Orbital Diseases
Shu-Lang Liao and Luke L.-K. Lin
Background: Color Doppler imaging (CDI) has been used in ophthalmology to
study vascular disorders including various orbital diseases. We report our experience
with CDI in orbital diseases and review the literature.
Patients and Methods: CDI was performed in selected patients with orbital
diseases such as carotid cavernous fistula, Graves’ ophthalmopathy, ocular melanoma,
and orbital tumors.
Results: Twenty-five patients underwent CDI. Seven had carotid cavernous
fistula, four had choroidal melanoma, eight had Graves’ ophthalmopathy, and six
had orbital tumors. In patients with carotid cavernous fistula, CDI revealed a
prominent dilated superior ophthalmic vein and spectral wave-form analysis showed
high-velocity arterialized blood flow in all cases. Patients with choroidal melanoma
had an arterial signal with flow. In patients with Graves’ ophthalmopathy, flow
velocities in the ophthalmic and central retinal arteries were not significantly different
from those in normal subjects. No blood flow signal was noted in patients with
cavernous hemangioma, lymphoid hyperplasia, or meningioma, while one patient
with hemangiopericytoma had multiple blood flow signals.
Conclusion: CDI offers several advantages over computed tomography and
magnetic resonance imaging in the evaluation of different orbital diseases. Safe,
dynamic, and cost-effective, CDI provides a convenient way to not only diagnose
and differentiate orbital tumors, but to monitor treatment efficacy as well.
(J Med Ultrasound 2004;12:43–8)
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INTRODUCTION
Color Doppler imaging (CDI) is a popular diagnostic
imaging method for studying vascular disorders and
is an alternative to invasive vascular techniques such
as venography and arteriography [1–3]. It enables
simultaneous bidimensional imaging and Doppler
evaluation of blood flow in orbital vessels such as
the ophthalmic artery, central retinal artery, posterior
ciliary artery, and superior ophthalmic vein (SOV).
CDI has been used in ophthalmology to study vascular
disorders such as central retinal vein occlusion, ocular
ischemic syndrome, anterior ischemic optic neuro-
pathy, and glaucoma [4–8]. Recently, it has been
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used to evaluate and diagnose different orbital dis-
eases [9–11].
In this report, we present our experience with
CDI in orbital diseases and review the literature.
PATIENTS AND METHODS
CDI was performed in selected patients with carotid
cavernous fistula (CCF), Graves’ ophthalmopathy,
ocular melanoma, and orbital tumors. All examina-
tions were performed using a Hewlett Packard Image
Point HX Doppler unit with a 7.5-MHz curvilinear
transducer (L1038, Andover, MA, USA). With the
patient in a supine position, the ultrasound trans-
ducer was applied to closed eyelids using sterile oph-
thalmic methylcellulose as a coupling gel. The SOV,
ophthalmic artery, and central retinal artery were
found. Flow velocity was measured in the SOV,
ophthalmic artery, and central retinal artery and/or
the artery inside the tumor. The physical principles
and technique of CDI have been reported [12].
RESULTS
Of the 25 patients who underwent CDI, seven had
CCF, four had choroidal melanoma, eight had Graves’
ophthalmopathy, and six had orbital tumors (includ-
ing cavernous hemangioma, hemangiopericytoma,
lymphoid hyperplasia, and meningioma). In patients
with CCF, CDI revealed a prominent dilated SOV
and spectral wave-form analysis showed high-velocity
arterialized blood flow. CDI showed an arterial sig-
nal with flow velocity inside the tumor in patients
with choroidal melanoma. In patients with Graves’
ophthalmopathy, the flow velocities in the ophthalmic
and central retinal arteries (mean peak systolic
velocity, 34.7 ( 11.6 and 8.8 ( 2.1 cm/s, respectively)
were not significantly different from those in normal
subjects (33.7 ( 8.3 and 9.6 ( 2.4 cm/s, respectively).
In addition, no SOV signal or velocity was detected.
Among patients with orbital tumors, no blood flow
signals were noted in those with cavernous hem-
angioma, lymphoid hyperplasia, or meningioma.
However, one patient with hemangiopericytoma
showed multiple blood flow signals on CDI.
Case reports
Case 1: a 22-year-old male with a history of trauma
complained of progressive proptosis and orbital pain
in the right eye for 6 months. Ocular examination
showed dilated corkscrew-like vessels on the con-
junctiva of the right eye (Fig. 1A). Best-corrected
visual acuity was 20/40 (right eye, OD) with a
positive relative afferent pupillary defect and 20/20
(left eye, OS). Exophthalmometric readings were 27
mm (OD) and 17 mm (OS). CDI revealed a prominent
dilated SOV. Spectral wave-form analysis showed
high-velocity arterialized blood flow (systolic veloci-
ty, 18.4 cm/s; diastolic velocity, 10.7 cm/s) (Fig. 1B).
Magnetic resonance imaging (MRI) showed a dilated
SOV and communication between the internal carotid
artery and cavernous sinus (Fig. 1C). Selective carotid
angiography showed a high-flow fistula between the
intracavernous position of the internal carotid artery
and the cavernous sinus. The patient underwent
embolization. CDI 1 month later revealed normal
laminar blood flow. The symptoms and signs resolved
and the best-corrected visual acuity improved to 20/20
(OD). Exophthalmos disappeared within 1 month.
Case 2: a 55-year-old man complained of blurred
vision and a curtain-like sensation in the right eye
for several months. Best-corrected visual acuity was
10/200 (OD) and 20/25 (OS). Fundus examination
showed a choroidal mass over the posterior retina.
CDI of the right eye revealed a mushroom-like
choroidal mass with an internal feeding artery. The
systolic flow velocity in this artery was 15.9 cm/s
(Fig. 2). The patient underwent enucleation and re-
construction of the orbital socket with a hydroxy-
apatite implant. The pathology proved to be choroi-
dal melanoma.
Case 3: a 46-year-old woman complained of
proptosis and changes in her refractive status in the
left eye for 6 months. The visual acuity was 20/20
with myopic correction (OD) and 20/20 with bare
eye (OS). Exophthalmometric readings were 16 mm
(OD) and 18 mm (OS). MRI revealed a well-defined
intraconal mass with indentation of the posterior
pole of the left eye (Fig. 3A). CDI of the left orbit
revealed a retrobulbar mass without any artery sig-
nal within the tumor (Fig. 3B). The patient under-
went orbital tumor removal and histology showed
a cavernous hemangioma.
DISCUSSION
CDI is a sonographic imaging technique that per-
mits noninvasive assessment of blood flow velocity
in orbital vessels; normal ocular circulation has been
reported [13–16]. CDI has also been used to
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Fig. 1. Case 1: a 22-year-old male with cavernous carotid
fistula. (A) Dilated corkscrew-like vessels on the
conjunctiva of the right eye. (B) Color Doppler imaging
shows high-velocity arterialized blood flow with systolic
velocity of 18.4 cm/s and diastolic velocity of 10.7 cm/s.
(C) Magnetic resonance imaging shows a dilated superior
ophthalmic vein and communication between the internal
carotid artery and cavernous sinus.
investigate alterations in blood flow parameters in
various disorders such as central retinal artery
occlusion, central retinal vein occlusion, glaucoma,
diabetes mellitus, ocular ischemic syndrome, uveitis,
and endophthalmitis [5,6,15,17,18]. The advantage
of CDI over other imaging modalities is its ability
to detect blood flow within a lesion. Previous series
have demonstrated the utility of CDI in identifying
vascular lesions of the orbit, including CCFs, orbital
arteriovenous malformations/varices, and superior
orbital vein thrombosis [18–20]. Although CDI has
proved useful in studying tumors in the eye and
throughout the body, less is known about its potential
role in evaluating tumors located within the orbit.
CDI and carotid cavernous fistula
Several studies have used CDI to diagnose and
monitor CCFs. Erickson et al reported the use of
CDI to study normal orbits and some orbital disor-
ders such as a presumed dural shunt [21]. Flaharty
et al described the use of CDI, showing dilated SOV
with reversed blood flow, to diagnose CCFs in three
cases [20]. Costa et al reported four cases in which
CDI was used to diagnose and monitor CCFs [22].
They also suggested that patients with direct CCFs
had higher blood flow velocity than those with dural
shunts.
In our experience, all cases with direct or indirect
CCF showed a dilated arterialized SOV on CDI.
Color imaging can differentiate the flow pattern
toward or against the probe and all cases in our
study showed reversal of blood flow from the orbital
apex to the globe in the SOV due to increased blood
pressure inside the cavernous sinus. All hemody-
namic changes disappeared in cases with resolu-
tion of the fistulas, either spontaneously or follow-
ing embolization. Compared to repeated carotid
angiography, CDI can be a useful tool for monitor-
ing the clinical course of CCFs, without additional
risks and at a lower cost.
CDI and Graves’ ophthalmopathy
To our knowledge, few reports of CDI of the orbital
vasculature in patients with Graves’ disease have
been published. Somer et al evaluated SOV flow
velocity in relation to various clinical and computed
tomography (CT) manifestations of thyroid eye
disease [10]. They reported that CT showed apical
crowding and horizontal plus vertical extraocular
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SOV blood flow velocity. In 18 orbits with thyroid
eye disease, SOV could not be detected with CDI.
The clinical and CT signs associated with a signifi-
cant decrease in SOV blood flow velocity and the
common findings among the orbits in which the
SOV could not be detected with CDI study suggest
that external compression of the SOV may contri-
bute to a decrease in SOV blood flow in orbits af-
fected by thyroid eye disease.
Alp et al reported that some orbital blood flow pa-
rameters are significantly changed in patients with
Graves’ ophthalmopathy compared with patients
with Graves’ disease without ophthalmopathy and
normal subjects [11]. They found that alterations in
blood flow parameters in the orbital vasculature in
patients with Graves’ disease may be due to Graves’
ophthalmopathy rather than Graves’ disease itself.
Moreover, they found that alterations in orbital arte-
rial blood flow velocities correlate with the degree
of extraocular muscle enlargement. They concluded
that orbital arterial blood flow velocities are in-
creased in patients with Graves’ ophthalmopathy
as a result of orbital inflammation.
In our limited experience, no SOV signal or
velocity was detected by CDI in patients with Graves’
ophthalmopathy. The findings were compatible with
previous studies.
CDI and orbital tumors
Hatton et al used CDI to study different kinds of
orbital diseases [9]. They found that the presence
of flow reversal when patients rotated their heads
while in the supine position supports the diagnosis
of a filling varix in a dependent position. Their
findings suggest that the absence of flow is more
consistent with benign lesions, whereas the presence
of intralesional flow may indicate malignancy or
malignant potential [10].
Several case series have also demonstrated low
flow in benign orbital tumors, including cavernous
hemangioma [23–25] and lacrimal gland adenoma
[23], and high flow in malignant lesions such as
fibrosarcoma [26]. In our experience, the absence
Fig. 3. Case 3: a patient with cavernous hemangioma.
(A) Magnetic resonance imaging reveals a well-defined
intraconal mass. (B) Color Doppler imaging reveals a
retrobulbar mass without any artery signal within the
tumor.
Fig. 2. Case 2: Color Doppler imaging of the choroidal
melanoma reveals a mushroom-like choroidal mass with
a feeding artery within the mass. The systolic flow velocity
in this artery was 15.9 cm/s.
A
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of flow in CDI examination may be associated with
benign lesions and favors observation.
CDI and choroidal melanoma
Histologic data indicate the importance of tumor
vascularization as a determinant of the biologic
behavior and response to radiotherapy in choroidal
melanoma. Several studies have examined the role
of CDI in diagnosis and management of choroidal
melanoma [26–28]. Wolff-Kormann et al used CDI
to quantitatively measure neovascular blood flow in
31 patients with choroidal melanoma, and blood
flow within the tumor was detected in 30 melanomas
[27]. Of the 20 patients in whom CDI was performed
to investigate the change in tumor blood flow after
radiotherapy, 19 showed a significant decrease in
peak systolic frequency. This occurred with and in
advance of a decrease in tumor size. In one patient,
an increasing maximum systolic frequency after
radiotherapy marked recurrent tumor growth. The
authors concluded that CDI might be a new diagnos-
tic modality for monitoring the effectiveness of
radiotherapy in choroidal melanoma. Guthoff et al
reported that Doppler shifts were detected using CDI
in 41 of 42 patients with malignant melanoma of
the uvea [28]. Doppler shifts were undetectable in
three tumors, markedly reduced in three tumors, and
unchanged in one tumor 1–4 months after ruthenium
plaque irradiation. The authors concluded that CDI
allowed a rapid overview of tumor vasculature and
facilitated study of individual vessels.
It is now commonly accepted that choroidal
melanomas and metastases are associated with
higher flow than benign choroidal lesions [26–
28]. Additionally, CDI can demonstrate a reduction
in flow within uveal melanomas after radiation
treatment, suggesting that it may be useful in
monitoring treatment efficacy [26–28]. In this study,
we found blood flow signals within the tumor in
all patients with choroidal melanoma. Because all
patients underwent enucleation of the eyeball, we
could not demonstrate changes in tumor blood flow
after radiotherapy.
CONCLUSION
CDI offers several advantages over CT and MRI in
the evaluation of different kinds of orbital diseases.
In addition to being safe, dynamic, and cost-effective,
and providing a convenient way to diagnose and
differentiate orbital tumors, CDI can be a useful tool
for monitoring treatment efficacy as well.
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